Literature DB >> 21807471

MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Ronald M Salomon1, John Karageorgiou, Mary S Dietrich, Jessica Y McLellan, Evonne J Charboneau, Jennifer U Blackford, Ronald L Cowan.   

Abstract

BACKGROUND: MDMA exposure is associated with chronic serotonergic dysfunction in preclinical and clinical studies. A recent functional magnetic resonance imaging (fMRI) comparison of past MDMA users to non-MDMA-using controls revealed increased spatial extent and amplitude of activation in the supplementary motor area during motor tasks (Karageorgiou et al., 2009). Blood oxygenation level dependent (BOLD) data from that study were reanalyzed for intraregional coherence and for inter-regional temporal correlations between time series, as functional connectivity.
METHODS: Fourteen MDMA users and ten controls reporting similar non-MDMA abuse performed finger taps during fMRI. Fourteen motor pathway regions plus a pontine raphé region were examined. Coherence was expressed as percent of voxels positively correlated with an intraregional index voxel. Functional connectivity was determined using wavelet correlations.
RESULTS: Intraregional thalamic coherence was significantly diminished at low frequencies in MDMA users compared to controls (p=0.009). Inter-regional functional connectivity was significantly weaker for right thalamo - left caudate (p=0.002), right thalamo - left thalamus (p=0.007), right caudate - right postcentral (p=0.007) and right supplementary motor area - right precentral gyrus (p=0.011) region pairs compared to controls. When stratified by lifetime exposure, significant negative associations were observed between cumulative MDMA use and functional connectivity in seven other region-pairs, while only one region-pair showed a positive association.
CONCLUSIONS: Reported prior MDMA use was associated with deficits in BOLD intraregional coherence and inter-regional functional connectivity, even among functionally robust pathways involving motor regions. This suggests that MDMA use is associated with long-lasting effects on brain neurophysiology beyond the cognitive domain.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807471      PMCID: PMC3224864          DOI: 10.1016/j.drugalcdep.2011.06.022

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

1.  Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.

Authors:  Una D McCann; Zsolt Szabo; Melin Vranesic; Michael Palermo; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Psychopharmacology (Berl)       Date:  2008-07-27       Impact factor: 4.530

2.  Volume, neuron density and total neuron number in five subcortical regions in schizophrenia.

Authors:  Pawel Kreczmanski; Helmut Heinsen; Valentina Mantua; Fritz Woltersdorf; Thorsten Masson; Norbert Ulfig; Rainald Schmidt-Kastner; Hubert Korr; Harry W M Steinbusch; Patrick R Hof; Christoph Schmitz
Journal:  Brain       Date:  2007-02-15       Impact factor: 13.501

3.  Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing.

Authors:  Patrizia Vannini; Ove Almkvist; Thomas Dierks; Christoph Lehmann; Lars-Olof Wahlund
Journal:  Psychiatry Res       Date:  2007-08-23       Impact factor: 3.222

4.  Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.

Authors:  Ronald L Cowan; Nicolas R Bolo; Mary Dietrich; Erica Haga; Scott E Lukas; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2007-06-18       Impact factor: 3.222

5.  Diffusion tensor imaging in MDMA users and controls: association with decision making.

Authors:  F Gerard Moeller; Joel L Steinberg; Scott D Lane; Matthew Buzby; Alan C Swann; Khader M Hasan; Larry A Kramer; Ponnada A Narayana
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

6.  Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.

Authors:  Gerry Jager; Maartje M de Win; Hylke K Vervaeke; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal:  Psychopharmacology (Berl)       Date:  2007-05-03       Impact factor: 4.530

7.  Neurotoxic effects of ecstasy on the thalamus.

Authors:  Maartje M L de Win; Gerry Jager; Jan Booij; Liesbeth Reneman; Thelma Schilt; Cristina Lavini; Sílvia D Olabarriaga; Nick F Ramsey; Gerard J den Heeten; Wim van den Brink
Journal:  Br J Psychiatry       Date:  2008-10       Impact factor: 9.319

8.  Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.

Authors:  Gerry Jager; Maartje M L de Win; Ingeborg van der Tweel; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal:  Neuropsychopharmacology       Date:  2007-04-25       Impact factor: 7.853

9.  MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.

Authors:  Norbert Gyongyosi; Brigitta Balogh; Eszter Kirilly; Tamas Kitka; Sandor Kantor; Gyorgy Bagdy
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

10.  Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.

Authors:  Joyce Colussi-Mas; Susan Schenk
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

View more
  9 in total

1.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Characterization of thalamo-cortical association using amplitude and connectivity of functional MRI in mild traumatic brain injury.

Authors:  Yongxia Zhou; Yvonne W Lui; Xi-Nian Zuo; Michael P Milham; Joseph Reaume; Robert I Grossman; Yulin Ge
Journal:  J Magn Reson Imaging       Date:  2013-09-06       Impact factor: 4.813

3.  Problem Drinking, Alcohol Expectancy, and Thalamic Resting-State Functional Connectivity in Nondependent Adult Drinkers.

Authors:  Simon Zhornitsky; Jaime S Ide; Wuyi Wang; Herta H Chao; Sheng Zhang; Sien Hu; John H Krystal; Chiang-Shan R Li
Journal:  Brain Connect       Date:  2018-10

4.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

Review 5.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

6.  Wavelet-transformed temporal cerebral blood flow signals during attempted inhibition of cue-induced cocaine craving distinguish prognostic phenotypes.

Authors:  Shing Chun Benny Lam; Ze Wang; Yin Li; Teresa Franklin; Charles O'Brien; Jeremy Magland; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2012-09-12       Impact factor: 4.492

Review 7.  3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Authors:  Jerrold S Meyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-21

8.  Cocaine, Appetitive Memory and Neural Connectivity.

Authors:  Suchismita Ray
Journal:  J Clin Toxicol       Date:  2012-07-13

9.  Disentangling Multispectral Functional Connectivity With Wavelets.

Authors:  Jacob C W Billings; Garth J Thompson; Wen-Ju Pan; Matthew E Magnuson; Alessio Medda; Shella Keilholz
Journal:  Front Neurosci       Date:  2018-11-06       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.